Keywords: adx48621, enters, ph, testing, geneva, switzerland-based, drugmaker

ADX48621 enters Ph I testing

Article | 16 April 2007

Print This

Geneva, Switzerland-based drugmaker Addex Pharma has initiated a Phase I study of ADX48621, a compound with a novel mechanism of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in